OM t of c.iii - Vision Research Coordinating Center - Washington ...
OM t of c.iii - Vision Research Coordinating Center - Washington ...
OM t of c.iii - Vision Research Coordinating Center - Washington ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
2/1/99 Chapter 4 Recruitment, Education, Consent page 4-3<br />
Form), it is part <strong>of</strong> the Study-related care at that visit. If the procedure is not on the<br />
CLEK Examination Form or if it is a non-CLEK Study Visit, it constitutes non-Study<br />
related care.<br />
4.5 Recruitment Publicity<br />
Keratoconus patients who are regular patients <strong>of</strong> the CLEK Clinic are the best<br />
candidates for the CLEK Study. Each Clinician should inform the other clinicians at his<br />
or her site <strong>of</strong> the need to inform him or her <strong>of</strong> any keratoconus patient or keratoconus<br />
suspect examined in the Clinic so that they may be screened for potential inclusion in<br />
the study. This is best done by presentations to all clinicians and by written<br />
memorandum to all clinicians and clinic staff. Initially this should be done in writing<br />
weekly for one month and then monthly for the remaining 9 months <strong>of</strong> the enrollment<br />
period.<br />
Other methods <strong>of</strong> patient recruitment include:<br />
• Announcements <strong>of</strong> the CLEK Study at local, state, and national research and<br />
continuing education meetings. A slide presentation will be provided to each<br />
Clinic Principal and Co-Investigator for use in such presentations.<br />
• Letters to colleagues requesting that they refer keratoconus patients to the<br />
Participating Clinic. These letters should be sent to every eye care practitioner in<br />
the Clinic’s area. Clinic Principal Investigators will be supplied with “CLEK<br />
Affiliate Doctors’ Certificates” to use in conjunction with their referring doctors.<br />
Referring doctors will receive CLEK Study patient newsletters.<br />
• Review <strong>of</strong> medical records <strong>of</strong> keratoconus patients and recalling these patients for<br />
screening for possible inclusion in the CLEK Study. This should be done by<br />
telephone calls (two, if necessary), then with at least two recall letters, and finally<br />
another telephone call.<br />
• Instructing Participating Clinic keratoconus patients and other Clinic patients<br />
about the CLEK Study with the CLEK patient brochure or by letter.<br />
Recruitment materials will be provided by the CLEK Executive Committee to the<br />
CLEK Participating Clinics. Use <strong>of</strong> other materials will require approval by the CLEK<br />
Executive Committee prior to their use.<br />
4.6 Informing Other Clinics <strong>of</strong> Successful Recruitment Strategies<br />
Each Participating Clinician will give a brief report <strong>of</strong> his or her Clinic’s<br />
recruitment strategies and his or her degree <strong>of</strong> success with those strategies at each